SMAD3 and pulmonary fibrosis: Increasing evidence shows that down-regulation of miR-29 is associated with fibrosis in a number of disease models including ischemic cardiac remodeling [26], while overexpression of miR-29b is capable of inhibiting Smad3-mediated kidney and lung fibrosis [23], [35].